Philip Coelho Joins Mediware Board( LENEXA Kan. Feb. 6 /- Mediware In...),Health

LENEXA, Kan., Feb. 6 /PRNewswire-FirstCall/ -- Mediware Information Systems (Nasdaq: MEDW) announced today the return of Mr. Philip Coelho to the board of directors. The Company also announced that long term director, Joseph Delario, resigned from the board following 16 years of valuable service.

Mr. Coelho, age 64, has more than 30 years senior level experience in high technology consumer electronic or medical device companies. He is the founder and currently the Chief Technology Architect of ThermoGenesis Corp, where he also currently serves on the board of directors and has had a variety of senior roles, including Chief Executive Officer from 1999 to 2007. He was President of Castleton Inc. from 1982 to 1986, and President of ESS Inc. from 1971 to 1982. Mr. Coelho is a member of the Society of Cryobiology and is the inventor or co-inventor of twenty-four patents in the fields of cell cryobiology, robotics, thermal processing of blood products and isolation of enzymes from blood. Mr. Coelho is also a member of the Board of Directors of Catalyst Pharmaceutical Partners, LLC. Mr. Coelho received a B.S. degree in thermodynamic and mechanical engineering from the University of California, Davis. Mr. Coelho previously served as a Mediware director, from December 2001 until February 2006.

"We are thrilled to welcome Phil back to the Mediware board," said Laurence Auriana, Mediware's chairman. "His experience with medical, biological and advanced care technologies will provide valuable guidance as Mediware rolls out its biologics management product."

Resigning from the board is Joseph Delario, age 74, who was been a director since 1992. Mr. Delario was President and Chief Executive Officer of Quadrocom, Inc., a business co
'/>"/>